Unmatched Benefits
- Tissue Regeneration
- Enhanced Oral Health
- Optimized Procedure Outcomes
ABOUT US
Who We Are
BioCellgraft is providing regenerative health therapies to enhance both soft and hard tissue in the oral cavity using Human Connective Tissue Matrix (HCTM) as well as other growth factors commonly known as an extracellular matrix.
The company’s value proposition with these products is that there is nothing available today for oral healthcare that maintains the ability to regenerate tissue. Our product offerings help patients with existing issues better than any products out today and help patients avoid oral and overall health issues due to the incredible positive health effect by strengthening the health of the oral cavity to treat and or to enable better procedure outcomes.
(These product offerings will begin to be made available to select practitioners and their patients in the second quarter of 2024)
Orafyl
Our regenerative Solution
Orafyl is a decellularized human placental connective tissue matrix (CTM)
Key Components
Biological Evaluation
MEET OUR TEAM
Leadership
BLOGS & NEWS
Explore our latest post
What The Experts Are Saying
During the clinical follow-up, it appeared that Orafyl® (BioCellgraft Inc., NY, USA) sustained a fast healing and an ad integrum recovery Read More
B. Husseini
Dr“We are excited to partner with Celularity to bring these exceptional regenerative therapies to the dental market in the United States. The existing data supports the tremendous opportunity we have to assist oral healthcare practitioners with extremely difficult indications which often involve painful procedures that are long and require many visits"
Michel Dard
CEO at BCG"Oral health is fundamental to overall health. This opportunity to manufacture placental-derived biomaterials for BioCellgraft will bring our exceptional, proven biomaterial technology to the treatment of oral healthcare concerns and fill the treatment gap for patients that suffer from soft tissue and hard tissue conditions”